5 recent pharmaceutical deals, acquisitions

Five deals and acquisitions completed by drugmakers since the beginning of June, as reported by Becker's Hospital Review:

  1. Novo Nordisk signed a deal to acquire Irish biotech Prothena's experimental anti-amyloid heart drug and broader amyloidosis program.

  2. Eli Lilly acquired Protomer Technologies, a biotech that engineers peptides and proteins.

  3. GlaxoSmithKline signed a deal with iTeos Therapeutics to co-develop and co-commercialize its experimental monoclonal antibody cancer treatment.

  4. Merck signed a deal with the U.S. government under which it will receive $1.2 billion for 1.7 million courses of its COVID-19 antiviral drug molnupiravir if it's FDA-authorized.

  5. Walgreens sold its wholesaling arm, Alliance Healthcare, to AmerisourceBergen for $6.5 billion.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars